Bristol-Myers Squibb and Celgene Enter Clinical Collaboration Agreement

News   Aug 21, 2014

 
Bristol-Myers Squibb and Celgene Enter Clinical Collaboration Agreement
 
 
 

RELATED ARTICLES

Reversing an Unstoppable Cancer Cascade with Proteomics

News

Mutations in genes that produce RAS proteins turn a normally benign process, essential for cellular growth, into a cancer stimulant that is currently undruggable. Now, cutting-edge protein analysis may help treat cancers caused by these mutations.

READ MORE

Understanding Inflammation From the Inside Out

News

Researchers have developed a method that enables them to genetically modify immune cells, multiply them and visualize them in living organisms. The technique will better evaluate and study the the inflammatory process.

READ MORE

A New, Streamlined Approach to Diagnosing and Treating Bowel Cancer

News

Researchers at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have discovered a faster, more cost-effective way to determine which DNA mutations cause human bowel cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE